2015
DOI: 10.1038/nchembio.1955
|View full text |Cite
|
Sign up to set email alerts
|

Structural determinants of reductive terpene cyclization in iridoid biosynthesis

Abstract: The carbon skeleton of ecologically and pharmacologically important iridoid monoterpenes is formed in a reductive cyclization reaction unrelated to canonical terpene cyclization. Here we report the crystal structure of the recently discovered iridoid cyclase (Catharanthus roseus) bound to a mechanism-inspired inhibitor that illuminates substrate binding and catalytic function of the enzyme. Key features that distinguish iridoid synthase from its close homologue, progesterone 5β-reductase, are highlighted.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
86
1
4

Year Published

2016
2016
2019
2019

Publication Types

Select...
8
2

Relationship

3
7

Authors

Journals

citations
Cited by 59 publications
(93 citation statements)
references
References 34 publications
(38 reference statements)
2
86
1
4
Order By: Relevance
“…It is possible that the flexibility of the NR active site loop can aid in the proper orientation of the substrate for catalysis. A similar role for the active site loop as an adaptive feature for allowing the binding of different substrates has been proposed for the SDRs that catalyze reductive terpene cyclization in iridoid alkaloid biosynthesis (36).…”
Section: Discussionmentioning
confidence: 99%
“…It is possible that the flexibility of the NR active site loop can aid in the proper orientation of the substrate for catalysis. A similar role for the active site loop as an adaptive feature for allowing the binding of different substrates has been proposed for the SDRs that catalyze reductive terpene cyclization in iridoid alkaloid biosynthesis (36).…”
Section: Discussionmentioning
confidence: 99%
“…Structural and mechanistic studies of ISY from C. roseus have revealed that the key active site residue is Tyr178 (37,39). This residue is also conserved in all ISY homologs identified from Nepeta (Figure 3).…”
Section: Sequence Of Nepeta Isymentioning
confidence: 99%
“…The enzymatic control of the initial reductive activation step has been structurally characterised in CrISY: crystal structures with cofactor and inhibitor or substrate show binding modes conducive to reduction and formation of an enolate intermediate [21][22][23] . Furthermore, this reduction is stereoselective, as exemplified by the comparison of CrISY, which produces 7S-4a, with AmISY, which produces the enantiomer 18 .…”
Section: Figurementioning
confidence: 99%